1-Aminocyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20050203191A1
SERIAL NO

11074326

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the treatment of behavioral disorders, especially agitation, associated with a central nervous system (CNS) disorder, especially Alzheimer's disease (AD), cerebrovascular disease (VaD), or Down's Syndrome, in a mammal, comprising administering to said mammal an 1-aminocyclohexane, alone or in combination with a acetylcholinesterase inhibitor. In one embodiment, the 1-aminocyclohexane is memantine.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERZ PHARMA GMBH & CO KGAAECKENHEIMER LANDSTRASSE 100 FRANKFURT AM MAIN 60318

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ferris, Steven New York, NY 1 10
McDonald, Scott Chatham, NJ 24 137
Moebius, Hans-Joerg Frankfurt, DE 11 174
Reisberg, Barry New York, NY 12 107
Stoffler, Albrecht Frankfurt Am Main, DE 3 32

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation